аЯрЁБс>ўџ 24ўџџџ1џџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџьЅС` №ПЭbjbjЫsЫs .ЉЉЭ џџџџџџЄ$$$$$$$8€€€€ Œ8ЊЌЌЌЌЌ‡‡‡)++++++$Кh"МO$‡‡‡‡‡O$$ЌЌлd‡^$Ќ$Ќ)‡)$$Ќ  €>’їШ€х)z0Њоћоо$$‡‡‡‡‡‡‡OOћ ‡‡‡Њ‡‡‡‡888$\ $888\ 888$$$$$$џџџџ DRUG DEVELOPMENT AND CLINICAL PHARMACOLOGY (MSc/PgDip/PgCert) 57B2DPB1/61B2DPVX/62B2DPVZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biomedical Sciences, Biology). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time or 18 months part-time (PgDip). Aim: To equip students for careers in the development, use and knowledge of new and current drugs. To achieve this the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical and clinical trials; and regulatory affairs. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and demonstrations in clinical departments. The curriculum excludes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; statistics; computing studies; industrial aspects of drug development; therapeutics; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety. Candidates shall be required to attend the following designated programme of courses: First Half-Session BT 5005 Introduction to Biobusiness (10 credit points) GS 50M1 Generic Skills (0 credit points) MT 5002 Molecular Pharmacology (20 credit points) MT 5003 Drug Metabolism and Toxicology (15 credit points) MT 5004 Therapeutics (10 credit points) MT 5009 Induction to Drug Development and Clinical Pharmacology (0 credit points) PU 5005 Applied Statistics (10 credit points) SK 5003 Information Skills (0 credit points) Second Half-Session BT 5504 Biobusiness Stage 2 (10 credit points) MT 5501 Pharmacovigilance (5 credit points) MT 5502 Drug Development to Evidence Based Medicine (20 credit points) MT 5503 Pharmacokinetics (10 credit points) Final Stage MSc only MT 5506 Omics and research (5 credit points) MT 5808 Project in Drug Development and Clinical Pharmacology (65 credit points) PgDip only MT 5807 Dissertation in Drug Development and Clinical Pharmacology (20 credit points) Assessment: By practical work, by written essays and by oral presentations, or by a combination of these, as prescribed for each course. The thesis/dissertation will be assessed and there may be an oral examination on completion of the programme. YZs" + “ — Ц Ю ј мчщёq{гоЬЭѓугѓгѓгѓгѓХѓХѓуѓуѓгѓСhjѓh8бhєm”>*OJQJ^Jh8бhєm”6OJQJ]^Jh8бhєm”5OJQJ\^Jh8бhєm”OJQJ^JYZ! " ’ “ Х Ц ъ ы A B U V  Ж ш "JœЪїј ѓчттттттттттнтаааааааааа „„„|ќ^„„`„|ќgdєm”gdєm”gdєm”  Ц 06$Тgdєm”  Ц 0D%Тgdєm”Эў  <hЏлмшщђpq|вгЬЭђђђђђђђђђђђђђђђэыgdєm” „„„|ќ^„„`„|ќgdєm”,1hА‚. АЦA!А"А# $ %ААФАФ Ф†œJ`ёџJ єm”Normal$a$CJOJQJ_HmH sH tH 8`8 єm” Heading 2$@&>*>`> єm” Heading 3$d8џ@&5DA@ђџЁD Default Paragraph FontRi@ѓџГR  Table Normalі4ж l4жaі (k@єџС(No ListЭ џџџџYZ!"’“ХЦъыABUVЖш"JœЪїј  <hЏлмшщђpq|вгЬ Я (@0€k(@0€k˜@0€Њl˜@0€Њl˜@0€Њl˜@0€Њl˜@0€Њl˜@0€Њl˜@0€Њl˜@0€Њl˜@0€Њl˜@0€Њl@0€Bи˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜@0€“q˜0€YZ!"’“ХЦъыABUVЖш"JœЪїј  <hЏлмшщђpq|вгЬ Я *@0€€*@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€š@0€€ 00Ь Э  Э Э №8№@ёџџџ€€€ї№’№№0№( № №№B №S №ПЫџ ?№0<Šny DUњџqvЯ  Я 3Я хXєm”jѓџ@>Fdl? FFЭ `@џџUnknownџџџџџџџџџџџџG‡z €џTimes New Roman5€Symbol3& ‡z €џArialY CG TimesTimes New Roman"qˆ№аhO,ШFP,ШFvWvW!№ ДД24Ш Ш 2ƒQ№HP)№џ?фџџџџџџџџџџџџџџџџџџџџџєm”2џџ=DRUG DEVELOPMENT AND CLINICAL PHARMACOLOGY (MSc/PgDip/PgCert)u06jp4u06jp4ўџр…ŸђљOhЋ‘+'Гй0Ј˜рьќ( 8D d p |ˆ˜ ф@DRUG DEVELOPMENT AND CLINICAL PHARMACOLOGY (MSc/PgDip/PgCert)u06jp4 Normal.dotu06jp41Microsoft Office Word@FУ#@вhїШ@`•ŒїШvWўџеЭеœ.“—+,љЎ08 hp˜ Ј АИРШ а ф51cgШ Ј >DRUG DEVELOPMENT AND CLINICAL PHARMACOLOGY (MSc/PgDip/PgCert) Title ўџџџўџџџ ўџџџ"#$%&'(ўџџџ*+,-./0ўџџџ§џџџ3ўџџџўџџџўџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџRoot Entryџџџџџџџџ РFpIO’їШ5€Data џџџџџџџџџџџџ1TableџџџџоWordDocumentџџџџ.SummaryInformation(џџџџџџџџџџџџ!DocumentSummaryInformation8џџџџџџџџ)CompObjџџџџџџџџџџџџqџџџџџџџџџџџџўџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџўџ џџџџ РFMicrosoft Office Word Document MSWordDocWord.Document.8є9Вq